Cancer Research Annual Meeting 2010  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 55, 467-471, February 1, 1995]
© 1995 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhuang, Z.
Right arrow Articles by Emmert-Buck, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhuang, Z.
Right arrow Articles by Emmert-Buck, M. R.

Identical Allelic Loss on Chromosome 11q13 in Microdissected in Situ and Invasive Human Breast Cancer

Zhengping Zhuang, Maria J. Merino, Rodrigo Chuaqui, Lance A. Liotta and Michael R. Emmert-Buck1

Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892

Human breast carcinoma is thought to develop through progressive stages from atypical hyperplasias to in situ carcinoma and finally to invasive and metastatic cancer. In situ breast carcinoma consists of small, isolated neoplastic foci which cannot be selectively studied by conventional methods. In this study, we used tissue microdissection to examine the loss of heterozygosity (LOH) of chromosome 11q13 in both in situ and invasive lesions of the breast, as compared to normal breast epithelium from the same patients. Forty-one cases of sporadic breast cancer were analyzed. Tissue microdissection allows for procurement and PCR-based analysis of small lesions using either frozen or formalin-fixed, paraffin-embedded tissue sections. LOH on chromosome 11q13 was found in 24 of 36 (67%) of the informative invasive breast cancer cases using two polymorphic DNA markers specific for this region (INT2 and PYGM). Twenty-one of the cases which demonstrated LOH in the invasive tumor also contained in situ carcinoma in the same tissue section. Seventy-one % (15 of 21) of the microdissected in situ lesions showed LOH of chromosome 11q13. Every case (15 of 15) of in situ tumor with LOH showed loss of the same allele in the corresponding invasive tumor cells. The results of this study suggest that a tumor suppressor gene located on chromosome 11q13 may play an important role in the early stages of development of sporadic human breast cancer. This finding provides molecular genetic support for the hypothesis that invasive breast cancer arises from in situ lesions.

1 To whom requests for reprints should be addressed, at Laboratory of Pathology, National Cancer Institute, Bldg. 10, Rm. 2N212, 9000 Rockville Pike, Bethesda, MD 20892.

Received 11/10/94. Accepted 12/19/94.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
Y.-C. Huang, C.-M. Lee, M. Chen, M.-Y. Chung, Y.-H. Chang, W. J.-S. Huang, D. M.-T. Ho, C.-C. Pan, T. T. Wu, S. Yang, et al.
Haplotypes, Loss of Heterozygosity, and Expression Levels of Glycine N-Methyltransferase in Prostate Cancer
Clin. Cancer Res., March 1, 2007; 13(5): 1412 - 1420.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
G. Arpino, R. Laucirica, and R. M. Elledge
Premalignant and In Situ Breast Disease: Biology and Clinical Implications
Ann Intern Med, September 20, 2005; 143(6): 446 - 457.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
L. Cheng, T. D. Jones, R. P. McCarthy, J. N. Eble, M. Wang, G. T. MacLennan, A. Lopez-Beltran, X. J. Yang, M. O. Koch, S. Zhang, et al.
Molecular Genetic Evidence for a Common Clonal Origin of Urinary Bladder Small Cell Carcinoma and Coexisting Urothelial Carcinoma
Am. J. Pathol., May 1, 2005; 166(5): 1533 - 1539.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
S. X. Liang, S. K. Chambers, L. Cheng, S. Zhang, Y. Zhou, and W. Zheng
Endometrial Glandular Dysplasia: A Putative Precursor Lesion of Uterine Papillary Serous Carcinoma. Part II: Molecular Features
International Journal of Surgical Pathology, October 1, 2004; 12(4): 319 - 331.
[Abstract] [PDF]


Home page
Am. J. Pathol.Home page
R. P. McCarthy, S. Zhang, D. G. Bostwick, J. Qian, J. N. Eble, M. Wang, H. Lin, and L. Cheng
Molecular Genetic Evidence for Different Clonal Origins of Epithelial and Stromal Components of Phyllodes Tumor of the Prostate
Am. J. Pathol., October 1, 2004; 165(4): 1395 - 1400.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
X.-J. Ma, R. Salunga, J. T. Tuggle, J. Gaudet, E. Enright, P. McQuary, T. Payette, M. Pistone, K. Stecker, B. M. Zhang, et al.
Gene expression profiles of human breast cancer progression
PNAS, May 13, 2003; 100(10): 5974 - 5979.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
V. L. Ernster, R. Ballard-Barbash, W. E. Barlow, Y. Zheng, D. L. Weaver, G. Cutter, B. C. Yankaskas, R. Rosenberg, P. A. Carney, K. Kerlikowske, et al.
Detection of Ductal Carcinoma In Situ in Women Undergoing Screening Mammography
J Natl Cancer Inst, October 16, 2002; 94(20): 1546 - 1554.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. J. Kim, M. Zhang, B. P. Vistica, C.-C. Chan, D.-F. Shen, E. F. Wawrousek, and I. Gery
Induction of Ocular Inflammation by T-Helper Lymphocytes Type 2
Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 758 - 765.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
D. F. Shen, D. M. Matteson, N. Tuaillon, B. K. Suedekum, R. R. Buggage, and C.-C. Chan
Involvement of Apoptosis and Interferon-{gamma} in Murine Toxoplasmosis
Invest. Ophthalmol. Vis. Sci., August 1, 2001; 42(9): 2031 - 2036.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. Gu, L. M. Roth, C. Younger, H. Michael, F. W. Abdul-Karim, S. Zhang, T. M. Ulbright, J. N. Eble, and L. Cheng
Molecular Evidence for the Independent Origin of Extra-ovarian Papillary Serous Tumors of Low Malignant Potential
J Natl Cancer Inst, August 1, 2001; 93(15): 1147 - 1152.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
F. Fend and M. Raffeld
Laser capture microdissection in pathology
J. Clin. Pathol., September 1, 2000; 53(9): 666 - 672.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
F. M. Waldman, S. DeVries, K. L. Chew, D. H. Moore II, K. Kerlikowske, and B.-M. Ljung
Chromosomal Alterations in Ductal Carcinomas In Situ and Their In Situ Recurrences
J Natl Cancer Inst, February 16, 2000; 92(4): 313 - 320.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
F. Fend, M. R. Emmert-Buck, R. Chuaqui, K. Cole, J. Lee, L. A. Liotta, and M. Raffeld
Immuno-LCM: Laser Capture Microdissection of Immunostained Frozen Sections for mRNA Analysis
Am. J. Pathol., January 1, 1999; 154(1): 61 - 66.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
M. R. Emmert-Buck, R. F. Bonner, P. D. Smith, R. F. Chuaqui, Z. Zhuang, S. R. Goldstein, R. A. Weiss, and L. A. Liotta
Laser Capture Microdissection
Science, November 8, 1996; 274(5289): 998 - 1001.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1995 by the American Association for Cancer Research.